Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Acro Biomedical's profit margin for the twelve months ending Sep 30, 2023 was -3534.4%. For fiscal 2022 it was -2410.2%, against -642.8% the year before. The highest annual figure on record is 5.2% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -2410.2% | −1767.4 |
| FY2021 | Dec 31, 2021 | -642.8% | −615.4 |
| FY2019 | Sep 30, 2019 | -27.4% | −32.6 |
| FY2018 | Sep 30, 2018 | 5.2% | +5.7 |
| FY2017 | Sep 30, 2017 | -0.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -1093.0% | −1033.2 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -1316.2% | −1310.6 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -644.3% | −650.7 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -158.9% | −164.2 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -59.8% | −63.3 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -5.5% | −11.1 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | 6.4% | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | 5.3% | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | 3.5% | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | 5.6% | – |
See a number that looks wrong?